Crosstalk between mitochondria–ER contact sites and the apoptotic machinery as a novel health meter

A Larrañaga-SanMiguel, N Bengoa-Vergniory… - Trends in Cell …, 2024 - cell.com
Mitochondria–endoplasmic reticulum (ER) contact sites (MERCS) function as transient
signaling platforms that regulate essential cellular functions. MERCS are enriched in specific …

cGAS-STING targeting offers novel therapeutic opportunities in neurological diseases

H Wang, JS Fleishman, S Wu, G Wang, L Du, J Li… - Ageing Research …, 2025 - Elsevier
Cyclic guanosine monophosphate (GMP)-adenosine monophosphate (AMP)(cGAMP)
synthase (cGAS) is a cytosolic DNA sensor that produces the secondary messenger cGAMP …

Genetic risk factors for late-onset Alzheimer's disease drive senescence in female tauopathy mice

T Hensley-McBain, ME Orr - Neuron, 2024 - cell.com
Carling et al. report that late-onset Alzheimer's disease (LOAD) risk alleles drive cellular
senescence, a hallmark of aging, in a tau-and sex-dependent manner. Mechanistic insights …

[HTML][HTML] Senescent brain cell types in Alzheimer's disease: Pathological mechanisms and therapeutic opportunities

HR Hudson, X Sun, ME Orr - Neurotherapeutics, 2025 - Elsevier
Cellular senescence is a cell state triggered by programmed physiological processes or
cellular stress responses. Stress-induced senescent cells often acquire pathogenic traits …

[HTML][HTML] Identification and development of cGAS inhibitors and their uses to treat Alzheimer's disease

J Alarcón-Espósito, RK Nagiri, L Gan, SC Sinha - Neurotherapeutics, 2025 - Elsevier
Abstract Cyclic GMP-AMP (cGAMP) synthase (cGAS) is a key component of the evolutionary
conserved immune response pathway, acting upstream stimulator of interferon genes …

Expansion of highly interferon‐responsive T cells in early‐onset Alzheimer's disease

DW Sirkis, C Warly Solsberg, TP Johnson… - Alzheimer's & …, 2024 - Wiley Online Library
INTRODUCTION Altered immune signatures are emerging as a central theme in
neurodegenerative disease, yet little is known about immune responses in early‐onset …

The role of interferon signaling in neurodegeneration and neuropsychiatric disorders

DW Sirkis, AP Oddi, C Jonson, LW Bonham… - Frontiers in …, 2024 - frontiersin.org
Recent advances in transcriptomics research have uncovered heightened interferon (IFN)
responses in neurodegenerative diseases including Alzheimer's disease, primary …

Innate and adaptive immunity in neurodegenerative disease

Y Huang, G Zhang, S Li, J Feng, Z Zhang - Cellular and Molecular Life …, 2025 - Springer
Neurodegenerative diseases (NDs) are a group of neurological disorders characterized by
the progressive loss of selected neurons. Alzheimer's disease (AD) and Parkinson's disease …

[HTML][HTML] Neurological Impact of Type I Interferon Dysregulation

A Mylonas - 2024 - intechopen.com
Type I interferons are a class of potent and tightly regulated cytokines important for antiviral
and anti-tumoural innate and adaptive immunity. Dysregulated production can have serious …